Statins and "chameleon-like" cutaneous eruptions: Simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man

Journal of Cutaneous Medicine and Surgery

Volumn 14, Issue 5, 2010, Pages 207-211

  Adams, Amy E ^a   Bobrove, Arthur M ^a   Gilliam, Anita C ^a  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; UNCLASSIFIED DRUG; ZOCAR;

AGED; ALLERGIC VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG WITHDRAWAL; FOLLICULITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LICHENOID ERUPTION; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PUSTULE; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN BLEEDING; VESICULAR RASH;

AGED; DRUG HYPERSENSITIVITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; SIMVASTATIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 77957976008     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2010.09042     Document Type: Article

References (20)

1. Todd PA, Goa KL. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1990;40:583-607.
2. Merck & Co. Highlights of prescribing information. Available at: http://www.merck.com/product/usa/pi-circulars/z/zocor.html (accessed June 2008).
3. Feldmann R, Mainetti C, Saurat JH. Skin lesions due to treatment with simvastatin (Zocor). Dermatology 1993;186:272.
4. Callen JP. Newly recognized cutaneous drug eruptions. Dermatol Clin 2007;25:255-61, viii.
5. Schmutz JL, Barbaud A, Trechot P. [Cutaneous adverse effects of statins]. Ann Dermatol Venereol 2008;135:253-4.
6. Schindl A, Trautinger F, Pernerstorfer-Schon H, et al. Porphyria cutanea tarda induced by the use of pravastatin. Arch Dermatol 1998;134:1305-6.
7. Namazi MR. Statins: novel additions to the dermatologic arsenal? Exp Dermatol 2004;13:337-9.
8. Krasovec M, Elsner P, Burg G. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology 1993;186:248-52.
9. Pfeiffer CM, Kazenoff S, Rothberg HD. Toxic epidermal necrolysis from atorvastatin. JAMA 1998;279:1613-4.
10. Konig C, Eickert A, Scharfetter-Kochanek K, et al. Linear IgA bullous dermatosis induced by atorvastatin. J Am Acad Dermatol 2001;44:689-92.
11. Gressier L, Pruvost-Balland C, Dubertret L, et al. [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. Ann Dermatol Venereol 2009;136:50-3.
12. Sebok B, Toth M, Anga B, et al. Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin). Acta Derm Venereol 2004;84:229-30.
13. Keough GC, Richardson TT, Grabski WJ. Pravastatin-induced lichenoid drug eruption. Cutis 1998;61:98-100.
14. Roger D, Rolle F, Labrousse F, et al. Simvastatin-induced lichenoid drug eruption. Clin Exp Dermatol 1994;19:88-9.
15. Oskay T, Kutluay L. Acute generalized exanthematous pustulosis induced by simvastatin. Clin Exp Dermatol 2003;28:558-9.
16. Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol) 1995;7:325-6.
17. Noel B, Panizzon RG. Lupus-like syndrome associated with statin therapy. Dermatology 2004;208:276-7.
18. Vasconcelos OM, Campbell WW. Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake. Muscle Nerve 2004;30:803-7.
19. Mehregan DR, Mehregan DA, Pakideh S. Cheilitis due to treatment with simvastatin. Cutis 1998;62:197-8.
20. Stoebner PE, Michot C, Ligeron C, et al. [Simvastatin-induced lichen planus pemphigoides]. Ann Dermatol Venereol 2003;130:187-90.